Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency.

Le Quellec S, Desjonqueres A, Rugeri L, Desmurs Clavel H, Farhat F, Mechtouff L, Dargaud Y.

Thromb J. 2018 Apr 4;16:6. doi: 10.1186/s12959-018-0162-8. eCollection 2018.

2.

After the SIPPET study: Position paper of the CoMETH, the French society of haemophilia.

Lebreton A, Castet S, Falaise C, Rugeri L, Schved JF, Wibaut B.

Haemophilia. 2018 Mar;24(2):e55-e57. doi: 10.1111/hae.13400. Epub 2018 Jan 9. No abstract available.

PMID:
29316084
3.
4.

Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease.

Penel-Page M, Meunier S, Fretigny M, Le Quellec S, Boisseau P, Vinciguerra C, Ternisien C, Rugeri L.

Platelets. 2017 Dec;28(8):825-828. doi: 10.1080/09537104.2017.1293811. Epub 2017 Apr 24.

PMID:
28436749
5.

Pre-analytical effects of pneumatic tube system transport on routine haematology and coagulation tests, global coagulation assays and platelet function assays.

Le Quellec S, Paris M, Nougier C, Sobas F, Rugeri L, Girard S, Bordet JC, Négrier C, Dargaud Y.

Thromb Res. 2017 May;153:7-13. doi: 10.1016/j.thromres.2016.12.022. Epub 2016 Dec 28.

PMID:
28292729
6.

Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study.

Dargaud Y, Rugeri L, Fleury C, Battie C, Gaucherand P, Huissoud C, Rudigoz RC, Desmurs-Clavel H, Ninet J, Trzeciak MC.

J Thromb Haemost. 2017 May;15(5):897-906. doi: 10.1111/jth.13660. Epub 2017 Mar 21.

PMID:
28231636
7.

A single-centre study of haemostatic outcomes of joint replacement in von Willebrand disease and control patients and an analysis of the literature.

Rugeri L, Ashrani AA, Nichols WL, Trousdale RT, Pruthi RK.

Haemophilia. 2016 Nov;22(6):934-942. doi: 10.1111/hae.13027. Epub 2016 Jul 6.

PMID:
27385645
8.

Genotyping might help therapeutic decision-making in patients with von Willebrand disease type 2 B.

Rugeri L, Fretigny M, Dargaud Y, Nougier C, Vinciguerra C.

Haemophilia. 2016 Sep;22(5):e439-43. doi: 10.1111/hae.12960. Epub 2016 Jun 28. No abstract available.

PMID:
27353798
9.

Correlation between laboratory coagulation testing and thromboelastometry is modified during management of trauma patients.

David JS, Durand M, Levrat A, Lefevre M, Rugeri L, Geay-Baillat MO, Inaba K, Bouzat P.

J Trauma Acute Care Surg. 2016 Aug;81(2):319-27. doi: 10.1097/TA.0000000000001109.

PMID:
27192467
10.

[Anesthetic management of severe or worsening postpartum hemorrhage].

Aya AG, Ducloy-Bouthors AS, Rugeri L, Gris JC.

J Gynecol Obstet Biol Reprod (Paris). 2014 Dec;43(10):1030-62. doi: 10.1016/j.jgyn.2014.10.001. Epub 2014 Nov 6. Review. French.

11.

Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia.

Jourdy Y, Nougier C, Rugeri L, Bordet JC, Sobas F, Negrier C.

Int J Lab Hematol. 2015 Apr;37(2):244-52. doi: 10.1111/ijlh.12275. Epub 2014 Jul 15.

PMID:
25041633
12.

Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients.

Scridon A, Girerd N, Rugeri L, Nonin-Babary E, Chevalier P.

Europace. 2013 Nov;15(11):1562-6. doi: 10.1093/europace/eut121. Epub 2013 May 19.

PMID:
23689486
13.

[Diagnosis and treatment of trauma-induced coagulopathy].

David JS, Roumagnac A, Rulliat É, Bernet C, Rugeri L, Marcotte G, Levrat A.

Transfus Clin Biol. 2012 Nov;19(4-5):165-73. doi: 10.1016/j.tracli.2012.07.004. Epub 2012 Oct 4. Review. French.

PMID:
23039961
14.

Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: a preliminary study.

David JS, Levrat A, Inaba K, Macabeo C, Rugeri L, Fontaine O, Cheron A, Piriou V.

J Trauma Acute Care Surg. 2012 Mar;72(3):703-7. doi: 10.1097/TA.0b013e31822c884d.

PMID:
22491557
15.

Early coagulopathy in trauma patients: an on-scene and hospital admission study.

Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, Hautin E, David JS, Négrier C, Allaouchiche B.

Injury. 2012 Jan;43(1):26-32. doi: 10.1016/j.injury.2010.11.003. Epub 2010 Nov 26.

PMID:
21112053
16.

[Assessment of the interest of using confirmatory test in ELISA with use of high concentration of heparin-induced thrombocytopenia].

Rissoul K, Madani M, Nougier C, Rugeri L, Negrier C.

Ann Biol Clin (Paris). 2010 Sep-Oct;68(5):555-60. doi: 10.1684/abc.2010.0465. French. Retraction in: Ann Biol Clin (Paris). 2010 Nov-Dec;68(6):740.

17.

[Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].

Alcantara M, Ducastelle S, Rugeri L, Dargaud Y.

Rev Med Interne. 2011 May;32(5):e59-61. doi: 10.1016/j.revmed.2010.06.008. Epub 2010 Jul 17. French.

PMID:
20638758
18.

Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.

Rugeri L, Quélin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y.

Haemophilia. 2010 Sep 1;16(5):771-7. doi: 10.1111/j.1365-2516.2010.02246.x. Epub 2010 Apr 8.

PMID:
20398070
19.

Endogenous thrombin potential, prothrombin fragment 1+2 and D-dimers during pregnancy.

Dargaud Y, Hierso S, Rugeri L, Battie C, Gaucherand P, Négrier C, Trzeciak MC.

Thromb Haemost. 2010 Feb;103(2):469-71. doi: 10.1160/TH09-10-0679. Epub 2009 Dec 18. No abstract available.

PMID:
20024504
20.

A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.

Dargaud Y, Rugeri L, Vergnes MC, Arnuti B, Miranda P, Negrier C, Bestion A, Desmurs-Clavel H, Ninet J, Gaucherand P, Rudigoz RC, Berland M, Champion F, Trzeciak MC.

Br J Haematol. 2009 Jun;145(6):825-35. doi: 10.1111/j.1365-2141.2009.07698.x. Epub 2009 Apr 15.

PMID:
19388925
21.

Contribution of genetical analysis for diagnosis of von Willebrand's disease type 2B.

Victor M, Rugeri L, Nougier C, Meunier S, Fretigny M, Negrier C, Vinciguerra C.

Haemophilia. 2009 Mar;15(2):610-2. doi: 10.1111/j.1365-2516.2008.01966.x. Epub 2009 Feb 1. No abstract available.

PMID:
19187192
22.

Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women. A rebuttal.

Dargaud Y, Rugeri L, Négrier C, Trzeciak MC, Ninet J.

Thromb Res. 2008;122(5):715-6; author reply 717-8. doi: 10.1016/j.thromres.2008.06.009. No abstract available.

PMID:
18675445
23.

An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy.

Dargaud Y, de Mazancourt P, Rugeri L, Hanss M, Borg JY, Gaucherand P, Negrier C, Trzeciak C.

Blood Coagul Fibrinolysis. 2008 Jul;19(5):447-52. doi: 10.1097/MBC.0b013e328300c7ff.

PMID:
18600098
24.

A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux Aalpha Arg439-->Cys.

Hanss M, Vergnes C, Rugeri L, Ffrench P, DE Mazancourt P.

J Thromb Haemost. 2008 Aug;6(8):1422-4. doi: 10.1111/j.1538-7836.2008.03013.x. Epub 2008 May 14. No abstract available.

25.

Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients.

Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS.

Br J Anaesth. 2008 Jun;100(6):792-7. doi: 10.1093/bja/aen083. Epub 2008 Apr 24.

26.

Thrombin-generating capacity in patients with von Willebrand's disease.

Rugeri L, Beguin S, Hemker C, Bordet JC, Fleury R, Chatard B, Negrier C, Dargaud Y.

Haematologica. 2007 Dec;92(12):1639-46.

27.

Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography.

Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allaouchiche B, Negrier C.

J Thromb Haemost. 2007 Feb;5(2):289-95. Epub 2006 Nov 16.

28.

Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.

Picard V, Nowak-Göttl U, Biron-Andreani C, Fouassier M, Frere C, Goualt-Heilman M, de Maistre E, Regina S, Rugeri L, Ternisien C, Trichet C, Vergnes C, Aiach M, Alhenc-Gelas M.

Hum Mutat. 2006 Jun;27(6):600. Erratum in: Hum Mutat. 2006 Nov;27(11):1160.

PMID:
16705712
29.

Management of pregnant women with increased risk of venous thrombosis.

Dargaud Y, Rugeri L, Ninet J, Negrier C, Trzeciak MC.

Int J Gynaecol Obstet. 2005 Sep;90(3):203-7.

PMID:
15964002
30.

Multiple arterial thromboses in a patient with primary antiphospholipid syndrome receiving a bromocriptine therapy.

Dargaud Y, Pariset C, Pinede L, Rugeri L, Mohammedi I, Trzeciak C, Negrier C, Ninet J.

Lupus. 2004;13(12):957-60.

PMID:
15645753
31.

A new ELISA assay for diagnosis of acquired von Willebrand syndrome.

Siaka C, Rugeri L, Caron C, Goudemand J.

Haemophilia. 2003 May;9(3):303-8.

PMID:
12694522
32.
33.

Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.

Vambergue A, Rugeri L, Gaveriaux V, Devos P, Martin A, Fermon C, Fontaine P, Jude B.

Thromb Res. 2001 Mar 1;101(5):367-75.

PMID:
11297753
34.

Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall.

Corseaux D, Meurice T, Six I, Rugeri L, Ezekowitz MD, Rouvier P, Bordet R, Bauters C, Jude B.

Circulation. 2000 Apr 25;101(16):2000-6.

35.

[Constitutional thrombophilias: indications of the biological profile and therapeutic consequences].

Trillot N, Rugeri L, Jude B.

Therapie. 1999 Jul Aug;54(4):413-8. Review. French.

PMID:
10667107
36.

Monocyte tissue factor response is decreased in patients with hyperlipidemia.

Rugeri L, Susen S, Bard JM, Corseaux D, Gavériaux V, Devos P, Lecerf JM, Duriez P, Jude B.

Thromb Res. 1999 Nov 15;96(4):283-92.

PMID:
10593431
37.

Relationships between severe neonatal thrombocytopenia and maternal characteristics in pregnancies associated with autoimmune thrombocytopenia.

Valat AS, Caulier MT, Devos P, Rugeri L, Wibaut B, Vaast P, Puech F, Bauters F, Jude B.

Br J Haematol. 1998 Nov;103(2):397-401.

PMID:
9827911
38.

[Impact of a quality approach for transfusion safety on prescription, circuit optimization, traceability].

Marey A, Coupez B, Gruca L, Vannier V, Renom P, Wibaut B, Rugeri L, Cossement C, Cosson A.

Transfus Clin Biol. 1997 Oct;4(5):469-84. French.

PMID:
9453808
39.

[Should the extended evaluation of bronchial adenocarcinoma be different from that of non-small cell lung carcinoma?].

Milleron B, Guigay J, Rugeri L, Rosencher L, Terrioux P, Beerblock K, Akoun G.

Rev Pneumol Clin. 1992;48(4):159-62. French.

PMID:
1338351

Supplemental Content

Loading ...
Support Center